Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 18, 2025
Safety, tolerability, and pharmacokinetics of intranasal 2-deoxy-D-glucose in normal healthy volunteers: A randomized, double-blind, placebo-controlled, single and multiple ascending dose phase 1 studyThorsten Bischof, Melanie Gsoellpointner, Katarina D Kovacevic Miljevic, et al.
Trials|April 9, 2022
Safety, tolerability, and efficacy of monoclonal CD38 antibody felzartamab in late antibody-mediated renal allograft rejection: study protocol for a phase 2 trialKatharina A Mayer, Klemens Budde, Philip F Halloran, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 12, 2022
Reduced immunogenicity of BNT162b2 booster vaccination in combination with a tetravalent influenza vaccination: results of a prospective cohort study in 838 health workersHelga Radner, Daniela Sieghart, Anselm Jorda, et al.
Journal of the American Society of Nephrology : JASN|January 14, 2021
A Randomized Clinical Trial of Anti-IL-6 Antibody Clazakizumab in Late Antibody-Mediated Kidney Transplant RejectionKonstantin Doberer, Michael Duerr, Philip F Halloran, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 2022
Multiparametric Prediction Models for Coronavirus Disease 2019 Vaccine Selection: Results of a Comparative Population-Based Cohort StudyDaniela Sieghart, Claudia A Hana, Helmuth Haslacher, et al.
Cardiovascular Research|October 5, 2021
Low-molecular-weight heparin use in coronavirus disease 2019 is associated with curtailed viral persistence: a retrospective multicentre observational studyDavid Pereyra, Stefan Heber, Waltraud C Schrottmaier, et al.
The New England Journal of Medicine|May 28, 2024
A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated RejectionKatharina A Mayer, Eva Schrezenmeier, Matthias Diebold, et al.
Frontiers in Cellular and Infection Microbiology|February 10, 2022
A Model Predicting Mortality of Hospitalized Covid-19 Patients Four Days After Admission: Development, Internal and Temporal-External ValidationStefan Heber, David Pereyra, Waltraud C Schrottmaier, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|March 19, 2024
Immunogenicity and safety of COVID-19 booster vaccination: A population-based clinical trial to identify the best vaccination strategyDaniela Sieghart, Claudia A Hana, Caroline Dürrschmid, et al.
Influenza and Other Respiratory Viruses|July 29, 2026
Impact of ABO Blood System on Immunogenicity and Vaccine Efficacy of COVID-19 Booster Vaccination-A Population-Based Study of 3066 IndividualsDaniela Sieghart, Galateja Jordakieva, Caroline Dürrschmid, et al.
Pageof 5